The PAVE (Portfolio Alternative Value Enablement) team is an exciting new Business Unit in the US Commercial organization. PAVE was formed to enable continued patient access by maximizing value in mature, alliance and royalty assets. PAVE accomplishes this goal by changing asset trajectories by using innovative, lean, AI-enabled go-to-market models that unlock potential. Our team operates with a bold, ambitious and financially focused portfolio mindset. We build capabilities with an entrepreneurial culture that emphasizes speed, collaboration, and disciplined execution to create a unique end-to-end commercial learning environment. This secondment focuses on Marketing Operations and Marketing for the largest portion of the PAVE portfolio – the 11 promoted Oncology and General Medicine brands, which generate >$1B in revenue. The Secondee will play a critical role in leading development of promotional content, both new and derived from prior materials, by collaborating with our third-party partner, Indegene. Equally important, the Director will actively guide operationalization, ensuring compliance through MLR review and GCMA approval. This work is vital to establishing the PAVE operating model to deliver value in 2026 and to maximizing long-term impact for PAVE and for the enterprise.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
5,001-10,000 employees